Role
Director
Signature
/s/ Abraham Ceesay
Stock symbol
CRL
Transactions as of
Jun 2, 2025
Transactions value $
$408,901
Form type
4
Date filed
6/4/2025, 04:45 PM
Previous filing
May 29, 2025
Next filing
Jun 13, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ceesay Abraham Director C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON /s/ Abraham Ceesay 2025-06-03 0001722140

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $128K +946 $135.04 946 Jun 2, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $281K +2.08K $135.04 2.08K Jun 2, 2025 Common Stock 2.08K $135.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The unvested restricted stock units vest upon the earlier of 6/2/2026 or the business day prior to the Company's next annual meeting of shareholders.
F2 The stock options become exercisable upon the earlier of 6/2/2026 or the business day prior to the Company's next annual meeting of shareholders.